Generic drug makerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in TürkiyeLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of Deva Holding A.S.Labelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 15, 2026, FDA's public records list Deva Holding AS - Cerkezkoy Subesi with 6 drug recalls. The most recent is a drug recall dated Jul 16, 2019: Temozolomide Capsules, 180 mg, packaged in a) 5-count bottle (NDC 67877-541-07), b) 14-c….
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Jul 16, 2019 | Temozolomide Capsules, 180 mg, packaged in a) 5-count bottle (NDC 67877-541-07), b) 14-count bottle (NDC 67877-541-14), Rx only, ManufactureClass II · CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products. | Drug recalls |
| Jul 16, 2019 | Temozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-07), b) 14-count bottle (NDC 67877-539-14), Rx only, ManufactureClass II · CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products. | Drug recalls |
| Jul 16, 2019 | Temozolomide Capsules, 20 mg, packaged in a) 5-count bottle (NDC 67877-538-07), b) 14-count bottle (NDC 67877-538-14), Rx only, ManufacturedClass II · CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products. | Drug recalls |
| Jul 16, 2019 | Temozolomide Capsules, 250 mg, 5-count bottle, Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, DistClass II · CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products. | Drug recalls |
| Jul 16, 2019 | Temozolomide Capsules, 140 mg, packaged in a) 5-count bottle (NDC 67877-540-07), b) 14-count bottle (NDC 67877-540-14), Rx only, ManufactureClass II · CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products. | Drug recalls |
| Jul 16, 2019 | Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 67877-537-07), b) 14-count bottle (NDC 67877-537-14), Rx only, Manufactured Class II · CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products. | Drug recalls |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
